Menu
Back to Journals » Clinical Ophthalmology » Volume 13
A paradigm shift in eye banking: how new models are challenging the status quo
Authors Moshirfar M, Goldberg JL, Brown TW, Wagner WD, Ronquillo YC
Received 26 July 2018
Accepted for publication 7 November 2018
Published 27 December 2018 Volume 2019:13 Pages 63—67
DOI https://doi.org/10.2147/OPTH.S181534
Checked for plagiarism Yes
Review by Single-blind
Peer reviewers approved by Dr Amy Norman
Peer reviewer comments 3
Editor who approved publication: Dr Scott Fraser
Majid Moshirfar,1–3 Jackson L Goldberg,4 Tanner W Brown,4 William D Wagner,5 Yasmyne C Ronquillo1
1HDR Research Center, Hoopes Vision, Draper, UT, USA; 2Department of Ophthalmology and Visual Sciences, John A. Moran Eye Center, University of Utah School of Medicine, Salt Lake City, UT, USA; 3Utah Lions Eye Bank, John Moran Eye Center, Murray, UT, USA; 4The University of Texas Health Science Center at Houston School of Medicine, Houston, TX, USA; 5Virginia Commonwealth University School of Medicine, Richmond, VA, USA
Abstract: This article presents a fact-based, direct approach in order to evaluate the strengths and short comings of both local eye banks and larger companies that have penetrated the market of eye donation. By taking a non-biased approach to the topic, the goal of this article is to create a platform, which furthers the discussion. We focus on SightLife and CorneaGen as well as local eye banks and how their models differ in terms of tissue procurement, distribution, and surgeon partnership.
Keywords: SightLife, CorneaGen, Lions Eye Bank, cornea transplant
This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License.
By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.